Loading advertisement
Logo
  • Shop Now
  • Help
  • Handicapping & PPs
  • Entries
  • Results
  • News & Info
  • Royal Ascot
  • Breeding
  • Harness
  • Help
  • Shop
  • DRF en Español
  • DRF Recommends
  • Bet on Sports
  • DRF Pro Services
  • DRF Form Finder
  • Horse Watch
Track Pages
Horse Racing News
Stakes Races
DRF TV
Race of the Day
International Racing
Beyer Speed Figures
DRF En Espanol

Lost in the Fog has his first chemotherapy treatment

Chuck Dybdal|Sep 07, 2006

Lost in the Fog, the 2005 Eclipse sprint champion, had his first of six planned chemotherapy treatments at the University of California at Davis on Thursday.

The 4-year-old colt was diagnosed with cancer last month. If he showed no adverse reaction to the treatment Thursday afternoon, he was to be returned to his stall at Golden Gate Fields on Friday, according to Dr. Gary Magdesian, who is handling the colt's treatment.

Lost in the Fog had previously undergone steroid treatment that failed to shrink the three tumors discovered in him last month.

Magdesian said that Lost in the Fog's blood work would be monitored closely between treatments as would his bone marrow. Lost in the Fog's chemotherapy sessions will be spaced three weeks apart.

DRF Headlines

View All 
Stay Updated Now

Get the latest racing news, expert picks, and exclusive analysis delivered to your inbox.

Sign Up for Newsletter

Interested in News?

Google News

Download DRF app on your smartphone.

Download appDownload app

Events

  • Royal Ascot
  • Hong Kong
  • More

News

  • Race of the Day
  • Track Pages
  • Latest News
  • Breeding
  • More

Tracks

  • Belmont at the
Big A
  • Churchill Downs
  • Gulfstream Park
  • Laurel Park
  • Woodbine

Handicapping & PPs

  • DRF Classic PPs
  • Formulator PPs
  • TimeformUS PPs
  • Daily Racing
Program
  • DRF Picks
  • More
Drf en espanolPurchase ppspreference center
Drf en espanolPurchase ppspreference center

© 2026 Daily Racing Form.  All rights reserved.

Careers
Help
Terms
Privacy

© 2026 Daily Racing Form.  All rights reserved.